Personalizing Prostate Cancer Treatment with AI: Insights from Artera скачать в хорошем качестве

Personalizing Prostate Cancer Treatment with AI: Insights from Artera

Read the full article on OncData for more insights: https://oncdata.com/artera-personaliz... 0:00 Introduction 1:30 ArteraAI Prostate Test 3:15 ASCO Abstracts on Digital Pathology and AI 6:20 Clinical Guidelines 8:33 Health Inequities 11:30 Conclusion In this episode of the Exploring Artificial Intelligence in Oncology podcast, Dr. Waqas Haque interviews Dr. Trevor Royce, Senior Medical Director at Artera, to discuss advancements in personalized prostate cancer treatment through AI. Dr. Royce explains how the ArteraAI Prostate Test leverages digital pathology and AI to guide treatment decisions, including androgen deprivation therapy (ADT), for patients with localized prostate cancer. Key insights from Dr. Royce include: How the ArteraAI Prostate Test aids in making tailored treatment decisions The test’s role in predicting treatment outcomes, improving patient care, and minimizing unnecessary therapies Artera’s expansion of AI-driven research into other cancer types, including breast cancer Addressing health inequities in prostate cancer treatment through accessible AI solutions This conversation provides a glimpse into how AI is revolutionizing cancer care, helping clinicians make more informed, patient-centered decisions. #ProstateCancer #PersonalizedMedicine #ArtificialIntelligence #CancerTreatment #ArteraAI #DigitalPathology #OncologyResearch #HealthEquity #CancerCare